Fig. 3.
Clinical response rate (cCR and PR) to neoadjuvant endocrine therapy with an aromatase inhibitor in BluePrint Luminal tumors (n = 53). cCR clinical complete response, PR partial response
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.